Milestone Pharmaceuticals Inc. (MIST) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Milestone Pharmaceuticals...

    NASDAQ: MIST · Real-Time Price · USD
    2.11
    -0.07 (-3.21%)
    At close: Oct 03, 2025, 3:59 PM
    2.12
    0.46%
    After-hours: Oct 03, 2025, 07:59 PM EDT

    Milestone Pharmaceuticals Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 25.31M 13.76M 7.64M 114.14M
    Short-Term Investments
    		 44.38M 52.24M 56.95M n/a
    Long-Term Investments
    		 n/a n/a n/a n/a
    Other Long-Term Assets
    		 n/a n/a -2.68M -926K
    Receivables
    		 2.39M 3.85M 1.21M 483K
    Inventory
    		 n/a n/a -331K -356K
    Other Current Assets
    		 n/a n/a n/a n/a
    Total Current Assets
    		 73.93M 73.03M 71.8M 118.92M
    Property-Plant & Equipment
    		 1.57M 2.19M 2.68M 926K
    Goodwill & Intangibles
    		 n/a n/a n/a n/a
    Total Long-Term Assets
    		 1.57M 2.19M 2.68M 926K
    Total Assets
    		 75.5M 75.23M 74.48M 119.85M
    Account Payables
    		 1.93M 3.98M 2.26M 4.38M
    Deferred Revenue
    		 n/a n/a n/a n/a
    Short-Term Debt
    		 571K n/a 495K 224K
    Other Current Liabilities
    		 2.55M 1.99M 2.08M 1.23M
    Total Current Liabilities
    		 8.13M 7.23M 6.14M 6.78M
    Long-Term Debt
    		 53.35M 49.77M n/a n/a
    Other Long-Term Liabilities
    		 n/a n/a n/a n/a
    Total Long-Term Liabilities
    		 54.23M 51.23M 2M 474K
    Total Liabilities
    		 62.35M 58.45M 8.13M 7.25M
    Total Debt
    		 54.8M 51.77M 2.49M 698K
    Book Value
    		 13.15M 16.77M 66.35M 112.6M
    Book Value Per Share
    		 0.21 0.39 1.56 2.69
    Common Stock
    		 288.05M 260.5M 273.9M 251.9M
    Retained Earnings
    		 -367.55M -326.03M -266.34M -206.32M
    Comprehensive Income
    		 53.08M 48.46M 34.35M -1.63M
    Shareholders Equity
    		 13.15M 16.77M 66.35M 112.6M
    Total Investments
    		 44.38M 52.24M 56.95M n/a

    Add to Watchlist